Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Landos Biopharma, Inc. | 27,272,727 | reported | 10 Jan 2023 | tx 2+30,909,090 |
| Solid Biosciences Inc. | 6,833,539 | reported | 11 Jan 2024 | tx 1+3,410,713 |
| Astria Therapeutics, Inc. | 4,873,721 | reported | 01 Feb 2024 | tx 1+2,481,350 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Feb 2024 | PURCHASE | Astria Therapeutics, Inc. | 2,481,350 | 12.09 USD | |
| 11 Jan 2024 | PURCHASE | Solid Biosciences Inc. | 3,410,713 | 5.53 USD | first after silence |
| 10 Jan 2023 | PURCHASE | Landos Biopharma, Inc. | 27,272,727 | 0.54 USD | deriv |
| 10 Jan 2023 | PURCHASE | Landos Biopharma, Inc. | 3,636,363 | 0.54 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 11 Jan 2024.